US FDA approves AstraZeneca's Imfinzi in combo with Imjudo plus chemotherapy to treat metastatic NSCLC

AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC)...

Three Trends in Pharma Turnkey Manufacturing

Companies are now partnering with an expert turnkey provider can streamline their development processes without the burden of costs associated with in-house manufacturing. In this article, let's look into the key trends in pharma turnkey projects.

How pharmaceutical marketing enables Pharma companies to provide customized solutions

How pharmaceutical marketing enables Pharma companies to provide customized solutions and how the advanced pharma marketers are shifting to precision marketing which is related to targeting on digital platforms with custom messaging.

Biogen hires former Sanofi head Viehbacher as CEO

Biogen Inc tapped former Sanofi boss Christopher Viehbacher as its new chief executive, betting on an industry veteran to help the U.S. drugmaker put behind it a series of setbacks for Alzheimer's drug Aduhelm...

AstraZeneca tops quarterly estimates buoyed by cancer drug sales

AstraZeneca topped analysts' expectations for third-quarter profit and revenue, helped by sales of its key cancer drugs, and raised its full-year adjusted earnings forecast....

Ayu Health receives additional funding of $5 million, storms into Hyderabad market

Ayu Health Hospitals, a fast-growing healthcare start-up with a network of 100+ hospitals across India, announced its maiden entry into Hyderabad. With the aim of providing healthcare for all, the company will be adding more hospitals to its...

Manipal Hospitals partners with Google Cloud uses Amwell to transform patient experience

Manipal Hospitals and Google Cloud have partnered ship to support the former to improve patient care, clinician experiences, and improve the hospital chain’s network efficiency...

Sun Pharma inks licensing pact with SPARC to commercialise medication in US market

Drug major Sun Pharma on said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market...

Lupin gets USFDA approval to market generic antibiotic drug in US

Drug firm Lupin on said it has received approval from the US health regulator to market Doxycycline Capsules used to treat bacterial infections in the American market...

Zydus Lifesciences gets USFDA Approval for generic hypertension drug

Zydus Lifesciences on said it has received nod from the US health regulator to market blood pressure lowering drug Bisoprolol Fumarate and Hydrochlorothiazide tablets in the American market. The company has received approval from the US Food and...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.